Infection of primary human macrophages with hepatitis C virus : induction of tumour necrosis factor- and interleukin 8 Free

Abstract

Hepatitis C virus (HCV) has been reported to replicate in monocytes/macrophages in infected patients. However, it is unclear whether macrophages are susceptible to infection and whether such an infection is consequential. Sera from 26 HCV-infected patients were incubated with primary human macrophages collected from healthy donors. Virus negative strand was detected by a enzyme-based strand-specific assay and virus sequences were analysed by single strand conformation polymorphism (SSCP) and sequencing. Concentrations of the cytokines tumour necrosis factor- (TNF-) and interleukin (IL)-1, IL-6, IL-8, IL-10 and IL-12p70 were measured in culture supernatants and respective mRNAs were analysed in cell extracts by quantitative RT-PCR. For 15 sera, HCV RNA was detectable in 2- and 3-week cultures from at least one donor. Virus negative strand was detected in 29 % of macrophage samples in this group. In four cases, HCV RNA sequences amplified from macrophages differed from those amplified from sera suggesting evolution during infection. Concentrations of TNF- and IL-8 were found to be significantly higher in supernatants from HCV-infected cultures. In conclusion, these preliminary data suggest that primary human macrophages are susceptible to HCV infection and this infection is associated with the induction of cytokines TNF- and IL-8.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19491-0
2004-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/1/vir850047.html?itemId=/content/journal/jgv/10.1099/vir.0.19491-0&mimeType=html&fmt=ahah

References

  1. Auffermann-Gretzinger S., Keeffe E. B., Levy S. 2001; Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171–3176
    [Google Scholar]
  2. Bain C., Fatmi A., Zoulim F., Zarski J. P., Trepo C., Inchauspe G. 2001; Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512–524
    [Google Scholar]
  3. Becker S., Quay J., Soukup J. 1991; Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147:4307–4312
    [Google Scholar]
  4. Beld M., Penning M., Lukashov V., McMorrow M., Roos M., Pakker N., van den Hoek A., Goudsmit J. 1998; Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504–512
    [Google Scholar]
  5. Bronowicki J. P., Loriot M. A., Thiers V., Grignon Y., Zignego A. L., Brechot C. 1998; Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28:211–218
    [Google Scholar]
  6. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J., Weiner A. J., Bradley D. W., Kuo G., Houghton M. 1991; Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 88:2451–2455
    [Google Scholar]
  7. Cook E. B., Stahl J. L., Lowe L., Chen R., Morgan E., Wilson J., Varro R., Chan A., Graziano F. M., Barney N. P. 2001; Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 254:109–118
    [Google Scholar]
  8. Daar E. S., Lynn H., Donfield S., Gomperts E., O'Brien S. J., Hilgartner M. W., Hoots W. K., Chernoff D., Arkin S., Wong W. Y., Winkler C. A. 2001; Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 183:589–595
    [Google Scholar]
  9. Greub G., Ledergerber B., Battegay M., Grob P., Perrin L., Furrer H., Burgisser P., Erb P., Boggian K., Piffaretti J. C., Hirschel B., Janin P., Francioli P., Flepp M., Telenti A. 2000; Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800–1805
    [Google Scholar]
  10. Herbein G., O'Brien W. A. 2000; Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med 223:241–257
    [Google Scholar]
  11. Hilfenhaus J., Groner A., Nowak T., Weimer T. 1997; Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion 37:935–940
    [Google Scholar]
  12. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., Sasaki Y., Kasahara A., Hori M. 1999; Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584–5591
    [Google Scholar]
  13. Khabar K. S., Al-Zoghaibi F., Al-Ahdal M. N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S. T., Siddiqui Y., Kessie G., Matsushima K. 1997; The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J Exp Med 186:1077–1085
    [Google Scholar]
  14. Lane B. R., Lore K., Bock P. J., Andersson J., Coffey M. J., Strieter R. M., Markovitz D. M. 2001; Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 75:8195–8202
    [Google Scholar]
  15. Lanford R. E., Sureau C., Jacob J. R., White R., Fuerst T. R. 1994; Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202:606–614
    [Google Scholar]
  16. Laskus T., Radkowski M., Wang L. F., Vargas H., Rakela J. 1997; Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 71:7804–7806
    [Google Scholar]
  17. Laskus T., Radkowski M., Wang L. F., Jang S. J., Vargas H., Rakela J. 1998; Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 248:164–171
    [Google Scholar]
  18. Laskus T., Radkowski M., Piasek A., Nowicki M., Horban A., Cianciara J., Rakela J. 2000a; Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 181:442–448
    [Google Scholar]
  19. Laskus T., Radkowski M., Wang L. F., Nowicki M., Rakela J. 2000b; Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 74:1014–1017
    [Google Scholar]
  20. Laskus T., Wang L. F., Radkowski M., Vargas H., Nowicki M., Wilkinson J., Rakela J. 2001; Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol 75:2059–2066
    [Google Scholar]
  21. Lehmann C., Sprenger H., Nain M., Bacher M., Gemsa D. 1996; Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol 147:123–130
    [Google Scholar]
  22. Lerat H., Rumin S., Habersetzer F., Berby F., Trabaud M. A., Trepo C., Inchauspe G. 1998; In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91:3841–3849
    [Google Scholar]
  23. Mahe Y., Mukaida N., Kuno K., Akiyama M., Ikeda N., Matsushima K., Murakami S. 1991; Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κ B and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759–13763
    [Google Scholar]
  24. Mogensen S. C. 1979; Role of macrophages in natural resistance to virus infections. Microbiol Rev 43:1–26
    [Google Scholar]
  25. Mori N., Mukaida N., Ballard D. W., Matsushima K., Yamamoto N. 1998; Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappa B-like sites. Cancer Res 58:3993–4000
    [Google Scholar]
  26. Mukaida N. 2000; Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391–398
    [Google Scholar]
  27. Murayama T., Kuno K., Jisaki F., Obuchi M., Sakamuro D., Furukawa T., Mukaida N., Matsushima K. 1994; Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 68:7582–7585
    [Google Scholar]
  28. Murayama T., Ohara Y., Obuchi M., Khabar K. S., Higashi H., Mukaida N., Matsushima K. 1997; Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF- κ B-binding sites of the interleukin-8 gene. J Virol 71:5692–5695
    [Google Scholar]
  29. Nakajima N., Hijikata M., Yoshikura H., Shimizu Y. K. 1996; Characterization of long-term cultures of hepatitis C virus. J Virol 70:3325–3329
    [Google Scholar]
  30. Navas S., Martin J., Quiroga J. A., Castillo I., Carreno V. 1998; Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 72:1640–1646
    [Google Scholar]
  31. Nowak T., Niedrig M., Bernhardt D., Hilfenhaus J. 1993; Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation. Dev Biol Stand 81:169–176
    [Google Scholar]
  32. Oliver K. G., Kettman J. R., Fulton R. J. 1998; Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin Chem 44:2057–2060
    [Google Scholar]
  33. Polyak S. J., Khabar K. S., Paschal D. M., Ezelle H. J., Duverlie G., Barber G. N., Levy D. E., Mukaida N., Gretch D. R. 2001a; Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75:6095–6106
    [Google Scholar]
  34. Polyak S. J., Khabar K. S., Rezeiq M., Gretch D. R. 2001b; Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75:6209–6211
    [Google Scholar]
  35. Sansonno D., Iacobelli A. R., Cornacchiulo V., Iodice G., Dammacco F. 1996; Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol 103:414–421
    [Google Scholar]
  36. Shimizu Y. K., Purcell R. H., Yoshikura H. 1993; Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A 90:6037–6041
    [Google Scholar]
  37. Shimizu Y. K., Igarashi H., Kanematu T., Fujiwara K., Wong D. C., Purcell R. H., Yoshikura H. 1997; Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 71:5769–5773
    [Google Scholar]
  38. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399
    [Google Scholar]
  39. Thomas D. L., Rich J. D., Schuman P., Smith D. K., Astemborski J. A., Nolt K. R., Klein R. S. 2001; Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis 183:973–976
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19491-0
Loading
/content/journal/jgv/10.1099/vir.0.19491-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed